Comparison between two concentrates with factor VIII inhibitor bypassing activity
- 31 March 1982
- journal article
- research article
- Published by Elsevier in Thrombosis Research
- Vol. 26 (1), 21-29
- https://doi.org/10.1016/0049-3848(82)90147-5
Abstract
No abstract availableThis publication has 17 references indexed in Scilit:
- The Effect of Activated Prothrombin-Complex Concentrate (FEIBA) on Joint and Muscle Bleeding in Patients with Hemophilia A and Antibodies to Factor VIIINew England Journal of Medicine, 1981
- The thrombogenicity of prothrombin complex concentrates: III. The relationship of thrombogenicity to the nature of the starting plasmaThrombosis Research, 1981
- Factor VIII Inhibitor bypassing activity: A suggested mechanism of actionThrombosis Research, 1981
- Factor VIII coagulant antigen in factor IX complex concentratesThrombosis Research, 1979
- Contact factors are responsible for the thrombogenicity of prothrombin complexThrombosis Research, 1979
- Assay of total factor XII and of activated factor XII in plasma with a chromogenic substrateThrombosis Research, 1979
- Prothrombin complex concentrate (Konyne) in the treatment of hemophilic patients with factor VIII inhibitorsThe Journal of Pediatrics, 1976
- Activated Prothrombin Concentrate for Patients with Factor VIII InhibitorsNew England Journal of Medicine, 1974
- Progressive inactivation of factor VII in the cold by heparinThrombosis Research, 1974
- Prothrombin-Complex Concentrates and ThrombosesNew England Journal of Medicine, 1974